Benefits
Glycemia and Insulinemia Improvement
Nexira in vivo study (high fat/sucrose diet model) showed inavea™ CINNAMON ACACIA improves blood glucose and insulin markers vs HFHS-induced dysbiosis controls. Mechanism: cinnamon glucose modulation + acacia prebiotic effects.
Strong Prebiotic Activity
Significant ability to modulate overall gut microbiota population at 5 g/day; promotion of beneficial bacteria including Parabacteroides distasonis (whose benefits on metabolic health markers like glycemia and weight have been substantiated by Wang 2019 and others).
Increased SCFA Production (Propionate and Butyrate)
Specifically increases propionate and butyrate (SCFAs with metabolic health benefits) — propionate supports gluconeogenesis modulation and satiety; butyrate is colonocyte fuel and has insulin-sensitizing effects.
Microbiome Modulation Under Metabolic Stress
Studied specifically under dysbiosis-inducing conditions (high fat / high sucrose diet) — demonstrates effects in challenging metabolic environments. Relevant to: Western diet patterns, prediabetes, metabolic syndrome contexts.
Dual Mechanism (Polyphenols + Fiber)
Combines cinnamon polyphenols (direct insulin-mimetic and antioxidant effects) with acacia prebiotic fiber (indirect microbiome-mediated metabolic effects). Distinct mechanisms with complementary metabolic benefits.
Subtle Cinnamon Taste
Pleasant warming cinnamon flavor; suitable for: warm beverages, baked goods, breakfast applications, functional shots.
Mechanism of action
Cinnamon Polyphenol Metabolic Effects
Cinnamon contains POLYPHENOLS including PROANTHOCYANIDINS (PACs), CINNAMTANNINS (B-type PACs unique to cinnamon), and other polyphenols. Mechanisms: insulin-mimetic effects (insulin receptor stimulation), enhanced glucose uptake in muscle/adipose, modulation of carbohydrate digestion enzymes.
Acacia Prebiotic Mechanism
Acacia gum supports beneficial bacteria, SCFA production, gut barrier — see acacia/Fibregum entries. Foundation for indirect metabolic benefits.
Parabacteroides distasonis Promotion
Specific bacterial species shown to support metabolic health markers (glycemia, weight); inavea™ CINNAMON ACACIA selectively promotes this beneficial species.
Propionate/Butyrate Specificity
Among SCFAs, propionate and butyrate are particularly metabolically active — increased production from this formulation supports specific metabolic health pathways.
Clinical trials
In vivo study of inavea™ CINNAMON ACACIA in high fat/high sucrose diet-induced dysbiosis model.
In vivo model under metabolic stress conditions.
Strong prebiotic activity, synergistic gut microbiome balance contribution, significant role in metabolic health improvement (glycemia and insulinemia).
Trial of cinnamon on glycemic markers in T2D patients.
T2D patients.
Cinnamon reduced fasting glucose and HbA1c. Established cinnamon-specific glycemic effects (foundation for combination formulations).